Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of ...

Hemlibra plus immunosuppressive therapy appears safe for use in acquired hemophilia A, according to initial results of a real ...

Morbidity and mortality remain high for patients with acquired hemophilia A, and advances in immunotherapy and hemostatic therapy are needed to improve outcomes. AHA is a rare disorder caused by ...

The case emphasizes the importance for clinician awareness of the potential for rare immune-mediated disorders, including acquired hemophilia A (AHA), following allogeneic hematopoietic stem cell ...

Seeing her husband and son assemble a grill reminds columnist Cazandra Campos-MacDonald how hemophilia care was a team effort for her family.